RANI
Rani Therapeutics Holdings Inc
0.7611$
+1.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 89.8% | 87.8% | 77.3% | 73.3% | 74.3% | 81.2% | 73.7% | 65.5% | 48.9% | 91.0% | 90.8% | 92.9% | |
| 7.1% | 10.1% | 12.9% | 10.3% | 9.8% | 10.3% | 41.9% | 60.5% | 40.9% | 31.8% | 18.6% | 8.0% | |
| 85.9% | 83.8% | 74.0% | 70.7% | 69.8% | 75.4% | 65.7% | 60.5% | 40.9% | 84.8% | 83.7% | 87.8% | |
| 0.3% | 0.3% | 0.4% | 0.2% | 0.5% | 1.2% | 2.5% | 0.1% | – | 3.5% | 4.1% | 3.6% | |
| -0.3% | – | – | – | – | – | – | – | – | – | – | – | |
| 50.6% | 56.1% | 72.8% | 87.3% | 86.7% | 90.5% | 122.2% | 154.2% | 218.1% | 29.2% | 31.5% | 21.1% | |
| 10.4% | 13.8% | 25.0% | 37.9% | 46.4% | 54.3% | 83.4% | 122.0% | 188.8% | 21.6% | 26.7% | 17.5% | |
| 2.9% | 9.7% | 18.3% | 31.2% | 37.2% | 44.9% | 67.7% | 95.8% | 143.9% | 2.7% | 2.8% | 2.2% | |
| 2.0% | 1.1% | 1.5% | 1.2% | 3.6% | 3.7% | 6.3% | 10.6% | 24.3% | 0.5% | 1.7% | 1.7% | |
| 39.9% | 42.3% | 39.0% | 39.4% | 31.1% | 26.2% | 24.5% | 13.2% | – | – | – | – | |
| 24.9% | 22.2% | 13.8% | 6.5% | 7.2% | 5.4% | -12.7% | -33.0% | -77.5% | 56.3% | 54.8% | 64.5% | |
| -93.4% | -125.9% | -150.2% | -199.4% | -215.8% | -280.9% | -456.7% | -691.6% | -1,206.0% | -226.2% | -269.1% | -241.6% | |
| 36.3% | 44.7% | 48.7% | 60.2% | 66.2% | 89.2% | 138.6% | 216.3% | 360.4% | 250.9% | 347.0% | 307.6% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.